» Articles » PMID: 2031690

The Reliability and Validity of a Scale to Measure HIV Risk-taking Behaviour Among Intravenous Drug Users

Overview
Journal AIDS
Date 1991 Feb 1
PMID 2031690
Citations 122
Authors
Affiliations
Soon will be listed here.
Abstract

The initiation and maintenance of substantial behaviour change is required to reduce the spread of HIV infection among the intravenous drug-using population. In order to ascertain the efficacy of interventions aimed at reducing HIV-related risk-taking behaviour among this population, valid and reliable (yet preferably short) instruments for measuring such behaviour are required. The HIV risk-taking behaviour scale (HRBS) is a brief 11-item interviewer-administered scale which examines the behaviour of intravenous drug users in relation to both injecting and sexual behaviour. This paper describes the construction of the scale, in addition to data evaluating its reliability and validity. Initial analyses indicate that the scale has satisfactory psychometric properties.

Citing Articles

Effectiveness of Extended Screening and Brief Intervention (X-SBI) on Substance Misuse and Related Outcomes in Correctional Settings.

Ghosh A, Pillai R, Vij J, Maulik P, Bhanker N, Thakur U Indian J Psychol Med. 2025; :02537176241313210.

PMID: 39911791 PMC: 11790474. DOI: 10.1177/02537176241313210.


Risky sexual behavior in Veterans seeking substance use and mental health treatment.

Tu J, Shaw R, Florimbio A, McCarthy K, Bonar E, Chermack S Addict Behav Rep. 2024; 20:100572.

PMID: 39659896 PMC: 11629558. DOI: 10.1016/j.abrep.2024.100572.


HIV risk assessment tools for identifying individuals who could benefit from pre-exposure prophylaxis: a systematic review protocol.

Oo M, Shukalek C, Kishibe T, Hull M, Tan D BMJ Open. 2024; 14(11):e090565.

PMID: 39515851 PMC: 11552022. DOI: 10.1136/bmjopen-2024-090565.


Integrated telehealth intervention to reduce chronic pain and unhealthy drinking among people living with HIV: protocol for a randomized controlled trial.

Palfai T, Bernier L, Kratzer M, Magane K, Fielman S, Otis J Addict Sci Clin Pract. 2024; 19(1):64.

PMID: 39238059 PMC: 11375999. DOI: 10.1186/s13722-024-00493-3.


Harm reduction-focused behavioral activation for people who inject drugs: Mixed methods outcomes from a pilot open trial.

Paquette C, Vierling A, Kane L, Linares Abrego P, Benson K, Jordan E J Subst Use Addict Treat. 2024; 167:209490.

PMID: 39179209 PMC: 11612634. DOI: 10.1016/j.josat.2024.209490.